The global HER2 breast cancer test market is witnessing steady development as healthcare systems adapt to disruptions caused by the coronavirus outbreak. The pandemic affected breast cancer screening, diagnosis, treatment, and follow-up care, with concerns about infection exposure prompting some patients to postpone appointments and procedures. Against this backdrop, telehealth platforms,...
